AVD
AMERICAN VANGUARD CORP
Company overview
- Market capitalization
- $52.81M
- Employees
- 739
- Latest publication
- 2026-09-29
About AMERICAN VANGUARD CORP
American Vanguard Corporation, through its subsidiaries, develops, manufactures, and markets synthetic, biological, and biorational products for agricultural, commercial, and consumer uses in the United States and internationally. The company synthesizes and formulates chemicals and ferments and extracts microbial products for crops, turf, ornamental plants, and human and animal health protection, such as insecticides, fungicides, herbicides, soil health, plant nutrition, molluscicides, growth regulators, soil fumigants, and biorationals in liquid, powder, and granular forms. It distributes its products through national distribution companies, buying groups, or co-operatives, as well as through sales offices, wholly owned distributors, sales force executives, and sales agents. American Vanguard Corporation was incorporated in 1969 and is headquartered in Newport Beach, California.
Financial statements
Income Quarterly
| Metric | Q2 20262026-06-30 · USD | Q1 20262026-03-31 · USD | Q4 20252025-12-31 · USD | Q2 20252025-06-30 · USD | Q4 20242024-12-31 · USD | Q1 20242024-03-31 · USD | Q4 20232023-12-31 · USD | Q3 20232023-09-30 · USD |
|---|---|---|---|---|---|---|---|---|
| Total Revenue | 116,754,000USD | 123,568,000USD | 150,688,000USD | 129,313,000USD | 165,647,000USD | 135,143,000USD | 172,180,000USD | 149,516,000USD |
| Cost Of Revenue | 82,041,000USD | 85,151,000USD | 108,079,000USD | 88,766,000USD | 142,804,000USD | 92,725,000USD | 117,545,000USD | 106,432,000USD |
| Gross Profit | 34,713,000USD | 38,417,000USD | 42,609,000USD | 40,547,000USD | 22,843,000USD | 42,418,000USD | 54,635,000USD | 43,084,000USD |
| Selling General Administrative | 26,623,000USD | 16,870,000USD | 13,762,000USD | 13,791,000USD | 67,273,000USD | 14,465,000USD | 25,197,000USD | 15,095,000USD |
| Income Tax Expense | 383,000USD | 124,000USD | 1,105,000USD | 765,000USD | — | 1,484,000USD | 712,000USD | 885,000USD |
| Net Income | -9,868,000USD | -4,145,000USD | -28,213,000USD | -849,000USD | -90,429,000USD | 1,552,000USD | 6,979,000USD | -325,000USD |
| Research Development | — | 5,271,000USD | 6,022,000USD | 5,803,000USD | 7,180,000USD | 5,706,000USD | 10,662,000USD | 9,080,000USD |
| Selling And Marketing Expenses | — | 10,619,000USD | 11,930,000USD | 11,633,000USD | — | 12,881,000USD | 5,736,000USD | 14,718,000USD |
| Unclassified Operating Expenses | — | 3,028,000USD | 2,943,000USD | 4,954,000USD | 111,806,000USD | 3,275,000USD | — | — |
| Total Operating Expenses | — | 35,788,000USD | 34,657,000USD | 36,181,000USD | 186,259,000USD | 36,327,000USD | 42,552,000USD | 38,893,000USD |
| Operating Income | — | 2,629,000USD | 7,952,000USD | 4,366,000USD | -70,026,000USD | 6,091,000USD | 12,083,000USD | 4,191,000USD |
| Interest Income | — | 2,000USD | 5,261,000USD | 4,450,000USD | 7,428,000USD | — | — | 44,000USD |
| Interest Expense | — | 5,079,000USD | 4,702,000USD | 4,115,000USD | 4,901,000USD | 3,693,000USD | 4,357,000USD | 3,384,000USD |
| Net Interest Income | — | -5,790,000USD | -5,335,000USD | -4,450,000USD | -4,559,000USD | -3,693,000USD | -4,357,000USD | -3,384,000USD |
| Income Before Tax | — | -4,021,000USD | -27,108,000USD | -84,000USD | -77,454,000USD | 3,036,000USD | 7,691,000USD | 560,000USD |
| Tax Provision | — | 124,000USD | 1,105,000USD | 765,000USD | 12,975,000USD | 1,484,000USD | 712,000USD | 885,000USD |
| Net Income From Continuing Ops | — | -4,145,000USD | -28,213,000USD | -849,000USD | -90,429,000USD | 1,552,000USD | 6,979,000USD | -325,000USD |
| Ebit | — | 1,058,000USD | -22,406,000USD | 4,031,000USD | — | 6,638,000USD | 13,040,000USD | 3,932,000USD |
| Ebitda | — | 5,743,000USD | -17,687,000USD | 8,734,000USD | — | 12,079,000USD | 18,724,000USD | 9,308,000USD |
| Depreciation And Amortization | — | 4,685,000USD | 4,719,000USD | 4,703,000USD | — | 5,441,000USD | 5,684,000USD | 5,376,000USD |
| Reconciled Depreciation | — | 4,685,000USD | 4,719,000USD | 4,703,000USD | 5,720,000USD | 5,441,000USD | 7,129,000USD | 5,376,000USD |
| Total Other Income Expense Net | — | -6,650,000USD | -35,060,000USD | -4,450,000USD | -52,283,000USD | -3,055,000USD | -4,392,000USD | -3,631,000USD |
| Net Income Applicable To Common Shares | — | — | -28,213,000USD | -849,000USD | -90,429,000USD | — | — | -325,000USD |
| Source | DisclosurePreliminary | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Income Yearly
| Metric | FY 20252025-12-31 · USD | FY 20232023-12-31 · USD | FY 20222022-12-31 · USD | FY 20212021-12-31 · USD | FY 20202020-12-31 · USD | FY 20192019-12-31 · USD | FY 20182018-12-31 · USD | FY 20172017-12-31 · USD |
|---|---|---|---|---|---|---|---|---|
| Total Revenue | 515,114,000USD | 579,371,000USD | 609,615,000USD | 557,676,000USD | 458,704,000USD | 468,186,000USD | 454,272,000USD | 355,047,000USD |
| Cost Of Revenue | 367,553,000USD | 400,207,000USD | 368,263,000USD | 386,953,000USD | 286,114,000USD | 290,832,000USD | 271,641,000USD | 207,655,000USD |
| Gross Profit | 147,561,000USD | 179,164,000USD | 241,352,000USD | 170,723,000USD | 172,590,000USD | 177,354,000USD | 182,631,000USD | 147,392,000USD |
| Research Development | 23,161,000USD | 38,025,000USD | 31,816,000USD | 28,855,000USD | 26,310,000USD | 24,070,000USD | 26,428,000USD | 26,076,000USD |
| Selling General Administrative | 53,082,000USD | 111,151,000USD | 53,456,000USD | 105,892,000USD | 36,084,000USD | 46,593,000USD | 42,981,000USD | 37,660,000USD |
| Selling And Marketing Expenses | 45,428,000USD | 5,736,000USD | 101,476,000USD | 5,201,000USD | 79,201,000USD | 80,470,000USD | 74,201,000USD | 56,862,000USD |
| Unclassified Operating Expenses | 12,123,000USD | — | 13,953,000USD | — | 8,087,000USD | — | — | — |
| Total Operating Expenses | 133,794,000USD | 155,869,000USD | 200,701,000USD | 139,777,000USD | 149,682,000USD | 151,133,000USD | 143,610,000USD | 120,598,000USD |
| Operating Income | 13,767,000USD | 23,295,000USD | 40,651,000USD | 30,946,000USD | 22,908,000USD | 26,221,000USD | 39,021,000USD | 26,794,000USD |
| Interest Income | 106,000USD | 368,000USD | 4,686,000USD | 4,477,000USD | 5,178,000USD | 182,000USD | 174,000USD | 41,000USD |
| Interest Expense | 16,670,000USD | 12,639,000USD | 4,121,000USD | 3,687,000USD | 5,267,000USD | 7,391,000USD | 4,198,000USD | 1,982,000USD |
| Net Interest Income | -18,470,000USD | -9,980,000USD | -3,954,000USD | -3,687,000USD | -5,178,000USD | -7,060,000USD | -3,629,000USD | -1,859,000USD |
| Income Before Tax | -47,203,000USD | 10,297,000USD | 35,965,000USD | 26,753,000USD | 18,322,000USD | 18,803,000USD | 33,596,000USD | 24,853,000USD |
| Income Tax Expense | 2,679,000USD | 2,778,000USD | 8,561,000USD | 8,166,000USD | 3,080,000USD | 5,202,000USD | 9,145,000USD | 4,443,000USD |
| Tax Provision | 2,679,000USD | 440,000USD | 8,561,000USD | 8,166,000USD | 3,080,000USD | 5,202,000USD | 9,145,000USD | 4,443,000USD |
| Net Income | -49,882,000USD | 7,519,000USD | 27,404,000USD | 18,587,000USD | 15,242,000USD | 13,601,000USD | 24,195,000USD | 20,274,000USD |
| Net Income From Continuing Ops | -49,882,000USD | 4,438,000USD | 27,404,000USD | 18,975,000USD | 15,242,000USD | 13,810,000USD | 24,451,000USD | 20,410,000USD |
| Ebit | -30,533,000USD | 22,936,000USD | 40,086,000USD | 30,828,000USD | 23,391,000USD | 26,221,000USD | 43,668,000USD | 32,016,000USD |
| Ebitda | -11,791,000USD | 44,716,000USD | 62,224,000USD | 57,000,000USD | 43,293,000USD | 44,864,000USD | 62,561,000USD | 48,974,000USD |
| Depreciation And Amortization | 18,742,000USD | 21,780,000USD | 22,138,000USD | 26,172,000USD | 19,902,000USD | 18,643,000USD | 18,893,000USD | 16,958,000USD |
| Reconciled Depreciation | 18,742,000USD | 21,894,000USD | 22,138,000USD | 22,229,000USD | 19,902,000USD | 18,643,000USD | 18,891,000USD | 16,959,000USD |
| Total Other Income Expense Net | -60,970,000USD | -12,998,000USD | -4,686,000USD | -4,193,000USD | -4,586,000USD | -7,418,000USD | -5,425,000USD | -1,941,000USD |
| Net Income Applicable To Common Shares | -49,882,000USD | 7,519,000USD | 27,404,000USD | 18,587,000USD | 15,242,000USD | 13,601,000USD | 24,195,000USD | 20,274,000USD |
| Minority Interest | — | — | — | — | 0USD | 0USD | -133,000USD | 87,000USD |
| Non Operating Income Net Other | — | — | — | — | — | — | -1,401,000USD | — |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Balance sheet Quarterly
| Metric | Q2 20262026-06-30 · USD | Q1 20262026-03-31 · USD | Q4 20252025-12-31 · USD | Q3 20252025-09-30 · USD | Q2 20252025-06-30 · USD | Q1 20252025-03-31 · USD | Q4 20242024-12-31 · USD | Q3 20242024-09-30 · USD |
|---|---|---|---|---|---|---|---|---|
| Total Assets | 635,343,000USD | 665,243,000USD | 596,537,000USD | 655,013,000USD | 651,978,000USD | 631,588,000USD | 636,721,000USD | 759,458,000USD |
| Cash And Equivalents | 43,901,000USD | — | 12,425,000USD | 16,795,000USD | 14,482,000USD | 11,805,000USD | 12,514,000USD | 11,880,000USD |
| Total Current Assets | 417,751,000USD | 443,550,000USD | 370,522,000USD | 406,468,000USD | 399,326,000USD | 377,848,000USD | 378,893,000USD | 425,105,000USD |
| Total Liabilities | 453,956,000USD | — | — | — | — | — | — | — |
| Total Current Liabilities | 168,796,000USD | 190,924,000USD | 209,446,000USD | 230,167,000USD | 208,744,000USD | 213,065,000USD | 232,350,000USD | 225,304,000USD |
| Short Long Term Debt | 2,250,000USD | 2,250,000USD | — | — | — | — | — | — |
| Net Receivables | 183,460,000USD | 186,708,000USD | 167,789,000USD | 180,581,000USD | 183,956,000USD | 172,940,000USD | 169,743,000USD | 159,687,000USD |
| Inventory | 181,382,000USD | 175,038,000USD | 176,034,000USD | 199,005,000USD | 191,497,000USD | 184,596,000USD | 179,292,000USD | 246,037,000USD |
| Property Plant Equipment Net | 51,178,000USD | 67,752,000USD | 69,829,000USD | 73,548,000USD | 74,494,000USD | 75,446,000USD | 77,904,000USD | 94,942,000USD |
| Intangible Assets | — | 136,071,000USD | 138,746,000USD | 143,407,000USD | 146,168,000USD | 147,668,000USD | 150,497,000USD | 164,480,000USD |
| Other Current Assets | — | 10,890,000USD | 14,274,000USD | 10,087,000USD | 9,391,000USD | 8,507,000USD | 7,615,000USD | 7,501,000USD |
| Total Liab | — | 475,623,000USD | 404,140,000USD | 434,025,000USD | 421,156,000USD | 404,234,000USD | 403,611,000USD | 431,550,000USD |
| Total Stockholder Equity | — | 189,620,000USD | 192,397,000USD | 220,988,000USD | 230,822,000USD | 227,354,000USD | 233,110,000USD | 327,908,000USD |
| Other Current Liab | — | 76,535,000USD | 80,488,000USD | 106,180,000USD | 97,180,000USD | 87,438,000USD | — | 114,731,000USD |
| Common Stock | — | 3,498,000USD | 3,492,000USD | 3,497,000USD | 3,478,000USD | 3,485,000USD | 3,479,000USD | 3,452,000USD |
| Capital Stock | — | 3,498,000USD | 3,492,000USD | 3,497,000USD | 3,478,000USD | 3,485,000USD | 3,479,000USD | 3,452,000USD |
| Retained Earnings | — | 150,855,000USD | 155,000,000USD | 183,213,000USD | 195,571,000USD | 196,420,000USD | 204,882,000USD | 295,310,000USD |
| Cash | — | 70,914,000USD | 12,425,000USD | 16,795,000USD | 14,482,000USD | 11,805,000USD | 12,514,000USD | 11,880,000USD |
| Cash And Short Term Investments | — | 70,914,000USD | 12,425,000USD | 16,795,000USD | 14,482,000USD | 11,805,000USD | 12,514,000USD | 11,880,000USD |
| Current Deferred Revenue | — | 14,438,000USD | 33,094,000USD | 31,234,000USD | 6,490,000USD | 24,460,000USD | — | 27,183,000USD |
| Net Debt | — | 212,228,000USD | 178,961,000USD | 183,794,000USD | 194,048,000USD | 174,753,000USD | 134,818,000USD | 189,047,000USD |
| Short Term Debt | — | 7,767,000USD | 5,765,000USD | 6,185,000USD | 6,302,000USD | 5,986,000USD | 0USD | 6,604,000USD |
| Short Long Term Debt Total | — | 283,142,000USD | 191,386,000USD | 200,589,000USD | 208,530,000USD | 186,558,000USD | — | 200,927,000USD |
| Long Term Debt | — | 264,384,000USD | 174,000,000USD | 182,250,000USD | 189,500,000USD | 167,498,000USD | 147,332,000USD | 178,749,000USD |
| Accounts Payable | — | 90,672,000USD | 87,505,000USD | 84,204,000USD | 96,778,000USD | 93,920,000USD | 69,159,000USD | 73,557,000USD |
| Property Plant Equipment Gross | — | 198,857,000USD | 198,566,000USD | 198,429,000USD | 197,792,000USD | 196,989,000USD | 198,815,000USD | 221,046,000USD |
| Accumulated Other Comprehensive Income | — | -11,062,000USD | -12,000,000USD | -11,406,000USD | -12,879,000USD | -16,904,000USD | — | -13,849,000USD |
| Common Stock Shares Outstanding | — | 28,649,000shares | 29,008,380shares | 28,511,000shares | 28,345,000shares | 28,271,000shares | 28,879,370shares | 28,173,000shares |
| Non Current Assets Total | — | 221,693,000USD | 226,015,000USD | 248,545,000USD | 252,652,000USD | 253,740,000USD | 257,828,000USD | 334,353,000USD |
| Non Current Liabilities Total | — | 284,699,000USD | 194,694,000USD | 203,858,000USD | 212,412,000USD | 191,169,000USD | 171,261,000USD | 206,246,000USD |
| Non Current Liabilities Other | — | 1,115,000USD | 923,000USD | 457,000USD | 967,000USD | 1,673,000USD | 1,601,000USD | 2,756,000USD |
| Non Currrent Assets Other | — | 14,501,000USD | 16,939,000USD | 7,027,000USD | 7,756,000USD | 9,004,000USD | 8,484,000USD | 14,701,000USD |
| Net Working Capital | — | 252,626,000USD | 161,076,000USD | 176,301,000USD | 190,582,000USD | 164,783,000USD | 146,543,000USD | 199,801,000USD |
| Unclassified Non Current Assets | — | 3,369,000USD | -16,939,000USD | -7,027,000USD | -7,756,000USD | -9,004,000USD | -8,484,000USD | -14,701,000USD |
| Unclassified Non Current Liabilities | — | 19,200,000USD | 19,771,000USD | 21,151,000USD | 21,945,000USD | 21,998,000USD | 22,328,000USD | 24,741,000USD |
| Unclassified Equity | — | 42,831,000USD | 42,413,000USD | 42,187,000USD | 41,174,000USD | 40,868,000USD | 21,270,000USD | 39,543,000USD |
| Good Will | — | — | 0USD | 21,040,000USD | 20,805,000USD | 20,291,000USD | 19,701,000USD | 48,012,000USD |
| Other Assets | — | — | 17,440,000USD | 10,550,000USD | 11,185,000USD | 10,335,000USD | 9,726,000USD | 26,919,000USD |
| Unclassified Current Liabilities | — | — | 2,594,000USD | 2,364,000USD | — | — | 163,191,000USD | 3,229,000USD |
| Unclassified Current Assets | — | — | — | — | — | — | 9,729,000USD | — |
| Source | DisclosurePreliminary | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Balance sheet Yearly
| Metric | FY 20252025-12-31 · USD | FY 20242024-12-31 · USD | FY 20232023-12-31 · USD | FY 20222022-12-31 · USD | FY 20212021-12-31 · USD | FY 20202020-12-31 · USD | FY 20192019-12-31 · USD | FY 20182018-12-31 · USD |
|---|---|---|---|---|---|---|---|---|
| Total Assets | 596,537,000USD | 636,721,000USD | 767,548,000USD | 726,313,000USD | 694,160,000USD | 680,293,000USD | 691,086,000USD | 593,587,000USD |
| Intangible Assets | 138,746,000USD | 150,497,000USD | 172,508,000USD | 184,664,000USD | 197,841,000USD | 197,514,000USD | 198,377,000USD | 186,583,000USD |
| Other Current Assets | 14,274,000USD | 7,615,000USD | 6,261,000USD | 15,850,000USD | 12,488,000USD | 18,789,001USD | 10,457,000USD | 10,096,000USD |
| Total Liab | 404,140,000USD | 403,611,000USD | 397,538,000USD | 356,334,000USD | 321,422,000USD | 319,557,000USD | 346,930,000USD | 264,357,000USD |
| Total Stockholder Equity | 192,397,000USD | 233,110,000USD | 370,010,000USD | 369,979,000USD | 372,738,000USD | 360,736,000USD | 344,156,000USD | 329,230,000USD |
| Other Current Liab | 80,488,000USD | 101,438,000USD | 84,430,000USD | 81,725,000USD | 84,792,000USD | 107,883,001USD | 62,027,000USD | 54,920,000USD |
| Common Stock | 3,492,000USD | 3,479,000USD | 3,467,000USD | 3,444,000USD | 3,426,000USD | 3,394,000USD | 3,324,000USD | 3,276,000USD |
| Capital Stock | 3,492,000USD | 3,479,000USD | 3,467,000USD | 3,444,000USD | 3,426,000USD | 3,394,000USD | 3,324,000USD | 3,276,000USD |
| Retained Earnings | 155,000,000USD | 204,882,000USD | 332,897,000USD | 328,745,000USD | 304,385,000USD | 288,182,000USD | 274,118,000USD | 262,840,000USD |
| Good Will | 0USD | 19,701,000USD | 51,199,000USD | 47,010,000USD | 46,260,000USD | 52,108,000USD | 46,557,000USD | 25,790,000USD |
| Other Assets | 17,440,000USD | 9,726,000USD | 1USD | 10,910,000USD | 28,780,000USD | 700,516,000USD | 21,186,000USD | 21,774,000USD |
| Cash | 12,425,000USD | 12,514,000USD | 11,416,000USD | 20,328,000USD | 16,285,000USD | 15,923,000USD | 6,581,000USD | 6,168,000USD |
| Cash And Equivalents | 12,425,000USD | 12,514,000USD | 11,416,000USD | 20,328,000USD | 16,285,000USD | 15,923,000USD | 6,581,000USD | 6,168,000USD |
| Cash And Short Term Investments | 12,425,000USD | 12,514,000USD | 11,416,000USD | 20,328,000USD | 16,285,000USD | 15,923,000USD | 6,581,000USD | 6,168,000USD |
| Total Current Assets | 370,522,000USD | 378,893,000USD | 432,021,000USD | 388,567,000USD | 342,000,000USD | 330,250,000USD | 336,199,000USD | 310,188,000USD |
| Total Current Liabilities | 209,446,000USD | 232,350,000USD | 230,495,000USD | 266,601,000USD | 223,061,000USD | 171,324,000USD | 138,638,000USD | 145,528,000USD |
| Current Deferred Revenue | 33,094,000USD | 52,675,000USD | 65,560,000USD | 110,597,000USD | 63,064,000USD | 32,652,000USD | 6,826,000USD | 20,043,000USD |
| Net Debt | 178,961,000USD | 155,293,000USD | 150,678,000USD | 55,920,000USD | 61,794,000USD | 103,883,999USD | 153,592,000USD | 90,503,000USD |
| Short Term Debt | 5,765,000USD | 6,136,000USD | 6,081,000USD | 5,279,000USD | 5,059,000USD | 4,187,999USD | 4,904,000USD | 4,030,000USD |
| Short Long Term Debt Total | 191,386,000USD | 167,807,000USD | 162,094,000USD | 76,248,000USD | 78,079,000USD | 119,806,999USD | 160,173,000USD | 100,701,000USD |
| Long Term Debt | 174,000,000USD | 147,332,000USD | 138,900,000USD | 51,477,000USD | 52,240,000USD | 107,442,000USD | 148,766,000USD | 96,671,000USD |
| Net Receivables | 167,789,000USD | 179,472,000USD | 194,793,000USD | 168,199,000USD | 158,921,000USD | 131,753,999USD | 155,848,000USD | 134,029,000USD |
| Inventory | 176,034,000USD | 179,292,000USD | 219,551,000USD | 184,190,000USD | 154,306,000USD | 163,784,000USD | 163,313,000USD | 159,895,000USD |
| Accounts Payable | 87,505,000USD | 69,159,000USD | 68,833,000USD | 69,000,000USD | 67,140,000USD | 59,253,000USD | 64,881,000USD | 66,535,000USD |
| Property Plant Equipment Net | 69,829,000USD | 77,904,000USD | 96,977,000USD | 95,162,000USD | 91,497,000USD | 77,580,000USD | 67,779,000USD | 49,252,000USD |
| Property Plant Equipment Gross | 198,566,000USD | 198,815,000USD | 217,604,000USD | 95,162,000USD | 91,497,000USD | 77,580,000USD | 67,779,000USD | 49,252,000USD |
| Accumulated Other Comprehensive Income | -12,000,000USD | -18,729,000USD | -5,963,000USD | -12,182,000USD | -13,784,000USD | -9,322,000USD | -5,698,000USD | -4,507,000USD |
| Common Stock Shares Outstanding | 28,426,000shares | 28,059,000shares | 28,533,000shares | 29,872,000shares | 30,410,000shares | 29,993,000shares | 29,656,000shares | 30,048,000shares |
| Non Current Assets Total | 226,015,000USD | 257,828,000USD | 335,527,000USD | 337,746,000USD | 352,160,000USD | 350,043,000USD | 354,887,000USD | 283,399,000USD |
| Non Current Liabilities Total | 194,694,000USD | 171,261,000USD | 167,043,000USD | 89,733,000USD | 98,361,000USD | 148,233,000USD | 208,292,000USD | 118,829,000USD |
| Non Current Liabilities Other | 923,000USD | 1,601,000USD | 3,138,000USD | 23,659,000USD | 26,115,000USD | 9,054,000USD | 19,393,000USD | 6,795,000USD |
| Non Currrent Assets Other | 16,939,000USD | 8,484,000USD | 11,994,000USD | 10,769,000USD | 11,892,000USD | 20,934,000USD | 21,186,000USD | 21,774,000USD |
| Net Working Capital | 161,076,000USD | 146,543,000USD | 201,526,000USD | 121,966,000USD | 118,939,000USD | 160,401,000USD | 197,561,000USD | 164,660,000USD |
| Unclassified Non Current Assets | -16,939,000USD | -8,484,000USD | — | -10,769,000USD | -24,110,000USD | -698,609,000USD | — | -21,774,000USD |
| Unclassified Current Liabilities | 2,594,000USD | 2,942,000USD | 5,591,000USD | — | 3,006,000USD | -32,652,000USD | — | — |
| Unclassified Non Current Liabilities | 19,771,000USD | 22,328,000USD | 25,005,000USD | -18,764,000USD | -25,341,000USD | -21,673,000USD | -11,047,000USD | -22,158,000USD |
| Unclassified Equity | 42,413,000USD | 39,999,000USD | 36,142,000USD | 102,190,000USD | 98,024,000USD | 93,248,000USD | 87,248,000USD | 79,901,000USD |
| Short Term Investments | — | — | -425,000USD | — | — | — | — | — |
| Deferred Long Term Liab | — | — | — | 14,597,000USD | 20,006,000USD | 23,560,000USD | 19,145,000USD | 15,363,000USD |
| Other Liab | — | — | — | 18,764,000USD | 25,341,000USD | 29,850,000USD | 32,035,000USD | 22,158,000USD |
| Treasury Stock | — | — | — | -55,662,000USD | -22,739,000USD | -18,160,000USD | -18,160,000USD | -15,556,000USD |
| Net Tangible Assets | — | — | — | 138,305,000USD | 128,637,000USD | 111,114,000USD | 99,222,000USD | 116,857,000USD |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Cash flow Quarterly
| Metric | Q1 20262026-03-31 · USD | Q4 20252025-12-31 · USD | Q3 20252025-09-30 · USD | Q2 20252025-06-30 · USD | Q1 20252025-03-31 · USD | Q4 20242024-12-31 · USD | Q3 20242024-09-30 · USD | Q2 20242024-06-30 · USD |
|---|---|---|---|---|---|---|---|---|
| Net Income | -4,144,999USD | -28,213,000USD | -12,358,000USD | -849,000USD | -8,462,000USD | -90,429,000USD | -25,742,000USD | -11,721,000USD |
| Depreciation | 4,685,000USD | 4,719,000USD | 4,576,000USD | 4,703,000USD | 4,744,000USD | 5,720,000USD | 5,897,000USD | 5,463,000USD |
| Stock Based Compensation | 186,000USD | 275,000USD | 760,000USD | 422,000USD | 559,000USD | 525,000USD | 1,135,000USD | 747,000USD |
| Other Non Cash Items | 2,159,999USD | 26,805,000USD | 1,081,000USD | 730,000USD | 1,088,000USD | 74,000USD | 688,000USD | 777,000USD |
| Change To Account Receivables | -19,088,000USD | 6,753,000USD | 4,228,000USD | -10,185,000USD | 6,892,000USD | — | 45,437,000USD | -6,383,000USD |
| Change To Inventory | 1,530,000USD | 22,800,000USD | -6,728,000USD | -5,064,000USD | -4,721,000USD | 64,607,000USD | -1,659,000USD | -18,417,000USD |
| Change In Working Capital | -37,938,000USD | 3,044,000USD | 19,248,000USD | -22,568,000USD | -19,943,000USD | 54,966,000USD | 54,700,000USD | -9,301,000USD |
| Total Cash From Operating Activities | -35,442,000USD | 5,953,000USD | 12,692,000USD | -19,260,000USD | -20,576,000USD | 33,772,000USD | 27,879,000USD | -13,250,000USD |
| Capital Expenditures | -971,000USD | -1,550,000USD | -1,426,000USD | -589,000USD | -458,000USD | -1,241,000USD | -1,162,000USD | -2,883,000USD |
| Free Cash Flow | -36,413,000USD | 4,403,000USD | 11,266,000USD | -19,849,000USD | -21,034,000USD | 32,531,000USD | 26,717,000USD | -16,133,000USD |
| Total Cashflows From Investing Activities | -973,000USD | -1,565,000USD | -985,000USD | -611,000USD | -446,000USD | -6,623,000USD | 17,000USD | -2,831,000USD |
| Net Borrowings | 111,000,000USD | -8,250,000USD | -7,250,000USD | 22,002,000USD | 20,167,000USD | -31,418,000USD | -33,781,000USD | — |
| Total Cash From Financing Activities | 95,010,000USD | -8,358,000USD | -9,417,000USD | 21,678,000USD | 19,801,000USD | -32,284,000USD | -34,737,000USD | 21,808,000USD |
| Sale Purchase Of Stock | -19,000USD | -1,432,000USD | 629,000USD | 11,000USD | -11,000USD | -1,432,000USD | -587,000USD | 14,000USD |
| Change In Cash | 58,489,000USD | -4,370,000USD | 2,313,000USD | 2,677,000USD | -709,000USD | 1,246,000USD | -6,069,000USD | 4,240,000USD |
| Begin Period Cash Flow | 12,425,000USD | 16,795,000USD | 14,482,000USD | 11,805,000USD | 12,514,000USD | 11,880,000USD | 17,949,000USD | 13,709,000USD |
| End Period Cash Flow | 70,914,000USD | 12,425,000USD | 16,795,000USD | 14,482,000USD | 11,805,000USD | 12,514,000USD | 11,880,000USD | 17,949,000USD |
| Other Cashflows From Investing Activities | -2,000USD | -15,000USD | 441,000USD | -49,000USD | 12,000USD | 1,065,000USD | -9,000USD | 52,000USD |
| Other Cashflows From Financing Activities | -16,234,000USD | 97,000USD | -2,463,000USD | -131,000USD | -687,000USD | -2,282,000USD | -587,000USD | -829,000USD |
| Dividends Paid | — | -2,510,000USD | 0USD | 0USD | 0USD | -2,510,000USD | -840,000USD | -836,000USD |
| Unclassified Financing Cash Flow | — | 3,737,000USD | — | — | — | 5,358,000USD | 1,058,000USD | 23,459,000USD |
| Investments | — | — | -985,000USD | -611,000USD | -446,000USD | -242,000USD | 17,000USD | -2,831,000USD |
| Unclassified Operating Cash Flow | — | — | — | -1,698,000USD | 1,438,000USD | 62,916,000USD | -8,799,000USD | — |
| Unclassified Investing Cash Flow | — | — | — | — | — | -6,205,000USD | 1,171,000USD | 2,831,000USD |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Cash flow Yearly
| Metric | FY 20252025-12-31 · USD | FY 20242024-12-31 · USD | FY 20232023-12-31 · USD | FY 20222022-12-31 · USD | FY 20212021-12-31 · USD | FY 20202020-12-31 · USD | FY 20192019-12-31 · USD | FY 20182018-12-31 · USD |
|---|---|---|---|---|---|---|---|---|
| Net Income | -49,882,000USD | -126,340,000USD | 7,519,000USD | 27,404,000USD | 18,587,000USD | 15,242,000USD | 13,601,000USD | 24,062,000USD |
| Depreciation | 18,742,000USD | 22,322,000USD | 21,780,000USD | 22,138,000USD | 22,229,000USD | 19,902,000USD | 18,643,000USD | 18,891,000USD |
| Stock Based Compensation | 2,016,000USD | 4,412,000USD | 6,138,000USD | 5,684,000USD | 6,880,000USD | 6,561,000USD | 7,160,000USD | 5,805,000USD |
| Other Non Cash Items | 29,704,000USD | 55,618,000USD | 3,977,000USD | 5,633,000USD | 5,846,000USD | -1,965,000USD | 1,403,000USD | 5,632,000USD |
| Change To Account Receivables | 7,688,000USD | 3,706,000USD | -16,710,000USD | -6,447,000USD | -24,347,000USD | 26,517,000USD | -9,650,000USD | -21,320,000USD |
| Change To Inventory | 6,287,000USD | 35,178,000USD | -27,315,000USD | -29,560,000USD | 8,130,000USD | 7,421,000USD | 3,817,000USD | -31,440,000USD |
| Change In Working Capital | -20,219,000USD | 48,006,000USD | -87,944,000USD | 2,965,000USD | 36,692,000USD | 48,488,000USD | -34,020,000USD | -42,483,000USD |
| Total Cash From Operating Activities | -21,191,000USD | 3,923,000USD | -58,748,000USD | 57,105,000USD | 87,318,000USD | 89,197,000USD | 9,403,000USD | 11,346,000USD |
| Capital Expenditures | -4,084,000USD | -7,688,000USD | -12,064,000USD | -14,554,000USD | -10,042,000USD | -11,249,000USD | -12,985,000USD | -27,697,000USD |
| Free Cash Flow | -25,275,000USD | -3,765,000USD | -70,812,000USD | 42,551,000USD | 77,276,000USD | 77,948,000USD | -3,582,000USD | -16,351,000USD |
| Total Cashflows From Investing Activities | -3,607,000USD | -6,623,000USD | -17,017,000USD | -14,470,000USD | -20,042,000USD | -35,795,000USD | -54,837,000USD | -27,697,000USD |
| Net Borrowings | 26,669,000USD | 8,431,000USD | 86,600,000USD | -1,000,000USD | -55,569,000USD | -41,623,000USD | 51,900,000USD | 18,975,000USD |
| Total Cash From Financing Activities | 23,704,000USD | 4,540,000USD | 66,737,000USD | -38,260,000USD | -65,871,000USD | -43,212,000USD | 46,406,000USD | 11,133,000USD |
| Dividends Paid | -2,510,000USD | -2,510,000USD | -3,384,000USD | -2,787,000USD | -2,382,000USD | -1,168,000USD | -2,323,000USD | -2,199,000USD |
| Sale Purchase Of Stock | -1,432,000USD | -1,432,000USD | -17,506,000USD | -36,069,000USD | -7,534,000USD | -421,000USD | -2,604,000USD | -7,287,000USD |
| Change In Cash | -89,000USD | 1,098,000USD | -8,912,000USD | 4,043,000USD | 362,000USD | 9,342,000USD | 413,000USD | -5,169,000USD |
| Begin Period Cash Flow | 12,514,000USD | 11,416,000USD | 20,328,000USD | 16,285,000USD | 15,923,000USD | 6,581,000USD | 6,168,000USD | 11,337,000USD |
| End Period Cash Flow | 12,425,000USD | 12,514,000USD | 11,416,000USD | 20,328,000USD | 16,285,000USD | 15,923,000USD | 6,581,000USD | 6,168,000USD |
| Other Cashflows From Investing Activities | 477,000USD | 1,065,000USD | 242,000USD | -1,209,000USD | -10,000,000USD | -24,546,000USD | -41,852,000USD | -19,647,000USD |
| Other Cashflows From Financing Activities | -3,389,000USD | 51,000USD | 1,027,000USD | 254,596,000USD | -1,129,000USD | -35,795,000USD | 51,333,000USD | -73,000USD |
| Unclassified Operating Cash Flow | -1,552,000USD | — | -10,218,000USD | -6,719,000USD | -2,916,000USD | — | 2,616,000USD | — |
| Unclassified Financing Cash Flow | 4,366,000USD | — | — | -253,000,000USD | — | 35,795,000USD | -51,900,000USD | 1,717,000USD |
| Investments | — | -6,623,000USD | -13,640,000USD | -14,470,000USD | -20,042,000USD | -35,795,000USD | -54,837,000USD | -27,697,000USD |
| Unclassified Investing Cash Flow | — | 6,623,000USD | 8,445,000USD | 15,763,000USD | 20,042,000USD | 35,795,000USD | 54,837,000USD | 47,344,000USD |
| Change To Liabilities | — | — | — | -5,565,000USD | 36,697,000USD | 17,721,000USD | -12,372,000USD | 4,623,000USD |
| Cash And Cash Equivalents Changes | — | — | — | 4,375,000USD | 448,000USD | 10,190,000USD | 972,000USD | -5,218,000USD |
| Issuance Of Capital Stock | — | — | — | — | 743,000USD | 721,000USD | 716,000USD | — |
| Exchange Rate Changes | — | — | — | — | — | — | — | 49,000USD |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Operating metrics
No operating metrics are currently published for this company.
Revenue breakdown
| Period | Dimension | Business / region | Revenue | Currency | Source |
|---|---|---|---|---|---|
| Q1 2026Quarterly · 2026-03-31 | Geography | International | 40,038,000 | USD | 0001193125-26-209203 |
| Q1 2026Quarterly · 2026-03-31 | Geography | United States | 83,530,000 | USD | 0001193125-26-209203 |
| Q3 2025Quarterly · 2025-09-30 | Geography | International | 56,770,000 | USD | 0001193125-25-273381 |
| Q3 2025Quarterly · 2025-09-30 | Geography | United States | 62,543,000 | USD | 0001193125-25-273381 |
| Q2 2025Quarterly · 2025-06-30 | Geography | International | 57,054,000 | USD | 0000950170-25-100730 |
| Q2 2025Quarterly · 2025-06-30 | Geography | United States | 72,259,000 | USD | 0000950170-25-100730 |
| Q1 2025Quarterly · 2025-03-31 | Geography | International | 43,023,000 | USD | 0001193125-26-209203 |
| Q1 2025Quarterly · 2025-03-31 | Geography | United States | 72,777,000 | USD | 0001193125-26-209203 |
| Q3 2024Quarterly · 2024-09-30 | Geography | International | 60,320,000 | USD | 0001193125-25-273381 |
| Q3 2024Quarterly · 2024-09-30 | Geography | United States | 57,987,000 | USD | 0001193125-25-273381 |
| Q2 2024Quarterly · 2024-06-30 | Geography | International | 56,909,000 | USD | 0000950170-25-100730 |
| Q2 2024Quarterly · 2024-06-30 | Geography | United States | 71,300,000 | USD | 0000950170-25-100730 |
| Q1 2024Quarterly · 2024-03-31 | Geography | International | 50,118,000 | USD | 0000950170-25-082654 |
| Q1 2024Quarterly · 2024-03-31 | Geography | United States | 85,025,000 | USD | 0000950170-25-082654 |
| Q3 2023Quarterly · 2023-09-30 | Geography | International | 62,517,000 | USD | 0000950170-24-125626 |
| Q3 2023Quarterly · 2023-09-30 | Geography | United States | 86,999,000 | USD | 0000950170-24-125626 |
| FY 2019Yearly · 2019-12-31 | Product | Crop — Amount Of Herbicides Sold | 181,686,000 | USD | 0001564590-20-009724 |
| FY 2019Yearly · 2019-12-31 | Product | Crop — Amount Of Insecticides Sold | 153,448,000 | USD | 0001564590-20-009724 |
| FY 2019Yearly · 2019-12-31 | Product | Crop — Other Including Plant Growth Regulators | 67,266,000 | USD | 0001564590-20-009724 |
| FY 2019Yearly · 2019-12-31 | Product | Non Crop | 65,786,000 | USD | 0001564590-20-009724 |
| Q3 2019Quarterly · 2019-09-30 | Product | Crop — Amount Of Herbicides Sold | 46,772,000 | USD | 0001564590-19-041104 |
| Q3 2019Quarterly · 2019-09-30 | Product | Crop — Amount Of Insecticides Sold | 35,847,000 | USD | 0001564590-19-041104 |
| Q3 2019Quarterly · 2019-09-30 | Product | Crop — Other Including Plant Growth Regulators And Distribution | 22,887,000 | USD | 0001564590-19-041104 |
| Q3 2019Quarterly · 2019-09-30 | Product | Non Crop Including Distribution Of Third Party Products | 19,378,000 | USD | 0001564590-19-041104 |
| Q2 2019Quarterly · 2019-06-30 | Product | Crop — Amount Of Herbicides Sold | 37,203,000 | USD | 0001564590-19-029861 |
| Q2 2019Quarterly · 2019-06-30 | Product | Crop — Amount Of Insecticides Sold | 36,509,000 | USD | 0001564590-19-029861 |
| Q2 2019Quarterly · 2019-06-30 | Product | Crop — Other Including Plant Growth Regulators And Distribution | 22,173,000 | USD | 0001564590-19-029861 |
| Q2 2019Quarterly · 2019-06-30 | Product | Non Crop Including Distribution | 17,219,000 | USD | 0001564590-19-029861 |
| Q1 2019Quarterly · 2019-03-31 | Product | Crop — Amount Of Herbicides Sold | 31,535,000 | USD | 0001564590-19-017164 |
| Q1 2019Quarterly · 2019-03-31 | Product | Crop — Amount Of Insecticides Sold | 40,183,000 | USD | 0001564590-19-017164 |
| Q1 2019Quarterly · 2019-03-31 | Product | Crop — Other Including Plant Growth Regulators And Distribution | 15,670,000 | USD | 0001564590-19-017164 |
| Q1 2019Quarterly · 2019-03-31 | Product | Non Crop Including Distribution | 12,288,000 | USD | 0001564590-19-017164 |
| FY 2018Yearly · 2018-12-31 | Product | Crop — Amount Of Herbicides Sold | 183,350,000 | USD | 0001564590-20-009724 |
| FY 2018Yearly · 2018-12-31 | Product | Crop — Amount Of Insecticides Sold | 150,595,000 | USD | 0001564590-20-009724 |
| FY 2018Yearly · 2018-12-31 | Product | Crop — Other Including Plant Growth Regulators | 58,360,000 | USD | 0001564590-20-009724 |
| FY 2018Yearly · 2018-12-31 | Product | Non Crop | 61,967,000 | USD | 0001564590-20-009724 |
| Q3 2018Quarterly · 2018-09-30 | Product | Crop — Amount Of Herbicides Sold | 41,882,000 | USD | 0001564590-19-041104 |
| Q3 2018Quarterly · 2018-09-30 | Product | Crop — Amount Of Insecticides Sold | 31,048,000 | USD | 0001564590-19-041104 |
| Q3 2018Quarterly · 2018-09-30 | Product | Crop — Other Including Plant Growth Regulators And Distribution | 22,424,000 | USD | 0001564590-19-041104 |
| Q3 2018Quarterly · 2018-09-30 | Product | Non Crop Including Distribution Of Third Party Products | 16,426,000 | USD | 0001564590-19-041104 |
| Q1 2018Quarterly · 2018-03-31 | Product | Crop — Amount Of Herbicides Sold | 32,185,000 | USD | 0001564590-18-011782 |
| Q1 2018Quarterly · 2018-03-31 | Product | Crop — Amount Of Insecticides Sold | 41,293,000 | USD | 0001564590-18-011782 |
| Q1 2018Quarterly · 2018-03-31 | Product | Crop — Other Including Plant Growth Regulators And Distribution | 17,840,000 | USD | 0001564590-18-011782 |
| Q1 2018Quarterly · 2018-03-31 | Product | Non Crop Including Distribution | 12,790,000 | USD | 0001564590-18-011782 |
| FY 2017Yearly · 2017-12-31 | Product | Crop — Amount Of Herbicides Sold | 124,529,000 | USD | 0001564590-20-009724 |
| FY 2017Yearly · 2017-12-31 | Product | Crop — Amount Of Insecticides Sold | 134,377,000 | USD | 0001564590-20-009724 |
| FY 2017Yearly · 2017-12-31 | Product | Crop — Other Including Plant Growth Regulators | 42,503,000 | USD | 0001564590-20-009724 |
| FY 2017Yearly · 2017-12-31 | Product | Non Crop | 53,638,000 | USD | 0001564590-20-009724 |
| Q4 2017Quarterly · 2017-12-31 | Product | Crop — Amount Of Herbicides Sold | 55,746,000 | USD | Legacy provider |
| Q4 2017Quarterly · 2017-12-31 | Product | Crop — Amount Of Insecticides Sold | 32,127,000 | USD | Legacy provider |
| Q4 2017Quarterly · 2017-12-31 | Product | Crop — Other Including Plant Growth Regulators | 11,824,000 | USD | Legacy provider |
| Q4 2017Quarterly · 2017-12-31 | Product | Non Crop | 16,797,000 | USD | Legacy provider |
| Q3 2017Quarterly · 2017-09-30 | Product | Crop — Amount Of Herbicides Sold | 32,717,000 | USD | 0001564590-18-027505 |
| Q3 2017Quarterly · 2017-09-30 | Product | Crop — Amount Of Insecticides Sold | 24,866,000 | USD | 0001564590-18-027505 |
| Q3 2017Quarterly · 2017-09-30 | Product | Crop — Other Including Plant Growth Regulators | 17,191,000 | USD | 0001564590-18-027505 |
| Q3 2017Quarterly · 2017-09-30 | Product | Non Crop | 15,201,000 | USD | 0001564590-18-027505 |
| Q2 2017Quarterly · 2017-06-30 | Product | Crop — Amount Of Herbicides Sold | 16,045,000 | USD | 0001564590-18-019422 |
| Q2 2017Quarterly · 2017-06-30 | Product | Crop — Amount Of Insecticides Sold | 39,442,000 | USD | 0001564590-18-019422 |
| Q2 2017Quarterly · 2017-06-30 | Product | Crop — Other Including Plant Growth Regulators | 10,096,000 | USD | 0001564590-18-019422 |
| Q2 2017Quarterly · 2017-06-30 | Product | Non Crop | 12,322,000 | USD | 0001564590-18-019422 |
| FY 2016Yearly · 2016-12-31 | Product | Crop — Amount Of Herbicides Sold | 123,540,000 | USD | 0001564590-19-007329 |
| FY 2016Yearly · 2016-12-31 | Product | Crop — Amount Of Insecticides Sold | 119,226,000 | USD | 0001564590-19-007329 |
| FY 2016Yearly · 2016-12-31 | Product | Crop — Other Including Plant Growth Regulators | 29,438,000 | USD | 0001564590-19-007329 |
| FY 2016Yearly · 2016-12-31 | Product | Non Crop | 39,909,000 | USD | 0001564590-19-007329 |
| FY 2015Yearly · 2015-12-31 | Product | Crop — Amount Of Herbicides Sold | 111,897,000 | USD | 0001564590-18-005662 |
| FY 2015Yearly · 2015-12-31 | Product | Crop — Amount Of Insecticides Sold | 117,180,000 | USD | 0001564590-18-005662 |
| FY 2015Yearly · 2015-12-31 | Product | Crop — Other Including Plant Growth Regulators | 29,013,000 | USD | 0001564590-18-005662 |
| FY 2015Yearly · 2015-12-31 | Product | Non Crop | 31,292,000 | USD | 0001564590-18-005662 |
Periods follow company fiscal calendars. Quarterly, annual and year-to-date amounts are shown separately. Missing values are not zero. Data may be delayed, incomplete or corrected; follow the disclosure links to verify figures.